BioLM
PrivateLast Round
Pre Seed
Mar 13, 2023
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioLM is a business and productivity software company that has developed a biological algorithm-based platform designed to run protein and DNA sequence classifiers, inference models, and custom de novo sequence generators.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Services & Consulting
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioLM Comparables
Compare BioLM with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 310.ai | 92% | |
| EvolutionaryScale | 87% | |
| Synthesize Bio | 87% | |
BioLM Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 13, 2023 |
BioLM Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 2048 Ventures | Pre Seed |
| Nvidia Inception | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 6, 2026
Hiring one role, representing 25% of current headcount.
BioLM Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioLM's valuation, stock price, and market status.